21 – 30 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Metabolic pathways in immune senescence and inflammaging : Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
2023) In Allergy: European Journal of Allergy and Clinical Immunology(
- Contribution to journal › Article
-
Mark
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Allergen provocation tests in respiratory research : building on 50 years of experience
(
- Contribution to journal › Article
-
Mark
Histology-based blood leukocyte profiling reveals parallel Th2 and Th17 signatures in seasonal allergic rhinitis
(
- Contribution to journal › Article
-
Mark
Ciliated (FOXJ1+) Cells Display Reduced Ferritin Light Chain in the Airways of Idiopathic Pulmonary Fibrosis Patients
(
- Contribution to journal › Article
-
Mark
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
(
- Contribution to journal › Article
-
Mark
Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD
(
- Contribution to journal › Article
-
Mark
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD
(
- Contribution to journal › Scientific review
-
Mark
Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics
(
- Contribution to journal › Letter
- 2021
-
Mark
Perinatal inflammation relates to early respiratory morbidity and lung function at 12 years of age in children born very preterm
(
- Contribution to journal › Article